Back to Search
STEVEN CROFT, M.D.
M.D.
Anesthesiology Physician
NPI: 1497957153IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
7940A(WY)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OTHER
Class of 2004
Research & Publications (20)
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials.
PMID 19113955·J Med Chem·2009
7-preclinical
Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: could androgens have a role in the aetiology of oesophageal adenocarcinoma?
PMID 19455396·Cancer Causes Control·2009
8-other
Anti-African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analogues.
PMID 19178775·J Pharm Pharmacol·2009
7-preclinical
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.
PMID 18378716·Antimicrob Agents Chemother·2008
7-preclinical
Kinetoplastids: related protozoan pathogens, different diseases.
PMID 18382742·J Clin Invest·2008
6-review
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
PMID 18278859·J Med Chem·2008
7-preclinical
Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study.
PMID 18205140·Biomed Chromatogr·2008
7-preclinical
Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
PMID 18279817·Acta Trop·2008
4-observational
Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies.
PMID 18278860·J Med Chem·2008
7-preclinical
Are emergency department junior doctors becoming less experienced in performing common practical procedures?
PMID 17711946·Emerg Med J·2007
8-other
Preparation of N-sulfonyl- and N-carbonyl-11-azaartemisinins with greatly enhanced thermal stabilities: in vitro antimalarial activities.
PMID 17768731·ChemMedChem·2007
8-other
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
PMID 17337512·J Antimicrob Chemother·2007
7-preclinical
Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives.
PMID 17908944·Antimicrob Agents Chemother·2007
7-preclinical
Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
PMID 17693090·Bioorg Med Chem·2007
7-preclinical
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
PMID 17628445·Int J Antimicrob Agents·2007
7-preclinical
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006.
PMID 17456237·Kinetoplastid Biol Dis·2007
8-other
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?
PMID 17350306·Microbes Infect·2007
7-preclinical
In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
PMID 17715126·J Antimicrob Chemother·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 COLLEGE DR
ROCK SPRINGS, WY 82901 - Phone
- (307) 352-8451
Quick Facts
- NPI
- 1497957153
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile